LPL Financial »

Abcellera Biologics shares owned by LPL Financial

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by LPL Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $35k 13k 2.60
2024-06-30 $86k 29k 2.96
2024-03-31 $298k 66k 4.53

More positions owned by LPL Financial

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Vanguard Index Fds Total Stk Mkt (VTI)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Us Treas Bd Etf (GOVT)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)

View all positions for LPL Financial

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Baillie Gifford & Co
Ing Investment Management
OrbiMed Advisors
Arrowpoint Asset Management
BlackRock
BlackRock
Renaissance Technologies
Tang Capital Management
Federated Investors
Two Sigma Investments
Guardian Capital Advisors
Two Sigma Advisers
Citadel Advisors
Novo A/S

View all funds holding Abcellera Biologics